IBL HealthCare Limited

IBLHL

PK0095501018

Drug Retailers

End-of-day quote Pakistan S.E. Other stock markets 03:30:00 27/05/2024 am IST			5-day change	1st Jan Change
33.11 ^PKR	+0.09%		-1.28%	-8.59%

29/04	IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
26/04	IBL Healthcare Limited Announces CEO Changes	CI

Ibl Healthcare Limited Reports Earnings Results for the Full Year Ended June 30, 2019

October 09, 2019 at 01:13 am IST

IBL HealthCare Limited announced earnings results for the full year ended June 30, 2019. For the full year, the company announced sales was PKR 1,584.972 million compared to PKR 1,358.297 million a year ago. Net income was PKR 121.376 million compared to PKR 149.340 million a year ago. Basic earnings per share was PKR 2.24 compared to PKR 2.76 a year ago.

Latest news about IBL HealthCare Limited

IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	29/04	CI
IBL Healthcare Limited Announces CEO Changes	26/04	CI
IBL Healthcare Limited Announces Board Changes	26/04	CI
IBL HealthCare Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	29/02	CI
IBL HealthCare Limited Reports Earnings Results for the First Quarter Ended September 30, 2023	01/11	CI
IBL HealthCare Limited Reports Earnings Results for the Full Year Ended June 30, 2023	06/23/06	CI
IBL HealthCare Limited Reports Earnings Results for the Full Year Ended June 30, 2023	06/23/06	CI
IBL HealthCare Limited Announces Executive Changes	27/23/27	CI
IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	02/23/02	CI
IBL HealthCare Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	01/23/01	CI
IBL HealthCare Limited Reports Earnings Results for the First Quarter Ended September 30, 2022	28/22/28	CI
IBL HealthCare Limited Reports Earnings Results for the Full Year Ended June 30, 2022	29/22/29	CI
IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	27/22/27	CI
IBL HealthCare Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	01/22/01	CI
IBL HealthCare Limited Reports Earnings Results for the First Quarter Ended September 30, 2021	26/21/26	CI
IBL HealthCare Limited Reports Earnings Results for the Third Quarter Ended March 31, 2021	29/21/29	CI
Ibl Healthcare Limited Appoints Munis Abdullah and Mobeen Alam as Non-Executive Directors	02/21/02	CI
Ibl Healthcare Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020	01/21/01	CI
IBL HealthCare Limited Proposes Final Cash Dividend for the Financial Year Ended June 30, 2020	02/20/02	CI
Ibl Healthcare Limited Reports Earnings Results for the Full Year Ended June 30, 2020	02/20/02	CI
IBL HealthCare Limited Appoints Mufti Zia Ul Islam as Chief Executive	18/20/18	CI
Ibl Healthcare Limited Reports Earnings Results for the Third Quarter Ended March 31, 2020	20/20/20	CI
Ibl Healthcare Limited Reports Earnings Results for the Second Quarter Ended December 31, 2019	28/20/28	CI
Ibl Healthcare Limited Reports Earnings Results for the Full Year Ended June 30, 2019	09/19/09	CI
Ibl Healthcare Limited Reports Earnings Results for the Third Quarter Ended March 31, 2019	16/19/16	CI

Chart IBL HealthCare Limited

Duration

Period

More charts

Company Profile

IBL HealthCare Limited is engaged in marketing, selling and distribution of healthcare products. The Company's product categories include nutrition, health, and wellness, ophthalmic, medical disposables, and pharmaceutical. The nutrition category includes toddlers, baby cereals, medical nutrition, lifestyle nutrition, specialty, and infant formulas. The health and wellness category includes consumer health, and hygiene and safety. The ophthalmic category includes vision care and pharma. The Medical Disposables category consists of renal care, critical care and anesthesia, non-drug, blood transfusion, IV administration, and medical gloves. The Pharmaceutical category consists of various products, such as Seapride, Luxave, Conifa, M-Floxin, Urisolin, Hyplar, Ezcolic, Clariza, and Eprazin. The Company is a subsidiary of The Searle Company Limited and International Brands Limited.

Sector

Drug Retailers

More about the company

Income Statement Evolution

More financial data

Sector Other Drug Retailers

	1st Jan change	Capi.
IBL HEALTHCARE LIMITED	-8.59%	1.02Cr
WALGREENS BOOTS ALLIANCE, INC.	-40.71%	1.38TCr
JD HEALTH INTERNATIONAL INC.	-26.34%	1.15TCr
YIFENG PHARMACY CHAIN CO., LTD.	+14.31%	640.59Cr
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-20.28%	632.32Cr
MATSUKIYOCOCOKARA & CO.	-11.33%	597.15Cr
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+72.00%	499.75Cr
NAHDI MEDICAL COMPANY	-3.36%	463.07Cr
CLICKS GROUP LIMITED	-6.21%	396.28Cr
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-18.47%	324.16Cr